Parkinson's disease: prospects for improved drug therapy

Author： Hagan J.J. Middlemiss D.N. Sharpe P.C. Poste G.H.

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.18, Iss.5, 1997-05, pp. : 156-163

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Delivery Systems for Imaging and Therapy of Parkinson’s Disease

Current Neuropharmacology, Vol. 14, Iss. 4, 2016-05 ,pp. : 376-391

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Iron in Neurodegeneration: Prospects for Pharmacotherapy of Parkinson's Disease

By Jellinger K.A.

Drugs & Aging, Vol. 14, Iss. 2, 1999-02 ,pp. : 115-140

Adis International

Access to resources Recommend Favorite

PPAR-γ: Therapeutic Prospects in Parkinson's Disease

Current Drug Targets, Vol. 14, Iss. 7, 2013-06 ,pp. : 743-751

Bentham Science Publishers

Access to resources Recommend Favorite

Apomorphine therapy in Parkinson's disease: a review

By Ul Haq Ihtsham Lewitt Peter A Fernandez Hubert H

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 16, 2007-11 ,pp. : 2799-2809

Informa Healthcare

Access to resources Recommend Favorite

Transplantation therapy for Parkinson’s disease

By Borlongan C.V.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 10, 2000-10 ,pp. : 2319-2330

Informa Healthcare

Access to resources Recommend Favorite